NDC 0591-5778-01 - Atenolol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-5778
- Requested NDC
- 0591-5778-01
- Package NDCs from labels
- 0591-5778-01
- Manufacturer
- Rebel Distributors Corp.
- Effective date
- 2009-06-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Atenolol Tablets, USP | Rebel Distributors Corp. | 2009-06-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Atenolol Tablets USP Revised: April 2006 Rx only | Watson Laboratories, Inc. | 2007-03-02 | HUMAN PRESCRIPTION DRUG LABELING |
| Atenolol Tablets USP Rx only | Watson Laboratories, Inc. | 2006-03-08 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0591-5778-01 | Atenolol | 100 in 1 BOTTLE | TABLET | 100 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| C2C3B3F1-D236-EC09-9934-C3F9BA96E04B | A32ECCC4-16D1-47A5-9E61-261F5D38638C | 2007-03-02 | Boxed warning, Warnings, Adverse reactions | C2C3B3F1-D236-EC09-9934-C3F9BA96E04B A32ECCC4-16D1-47A5-9E61-261F5D38638C | ||
| D18BCF6D-2F2D-4F70-735B-4CAD05CE9AF4 | A5C67C7A-0FFD-4C51-BADB-B5109D4D25B6 | 2006-03-08 | Warnings, Adverse reactions | D18BCF6D-2F2D-4F70-735B-4CAD05CE9AF4 A5C67C7A-0FFD-4C51-BADB-B5109D4D25B6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.